Lv4
553 积分 2020-10-22 加入
Pep2MARS: Automated Cyclic Peptide Parameterization for Molecular Dynamics and Compound Design
11天前
已完结
A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases
29天前
已完结
Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
2个月前
已完结
Perspectives on the use of machine learning for ADME prediction at AstraZeneca
2个月前
已完结
Structures and mechanism of the human mitochondrial pyruvate carrier
4个月前
已完结
Implementation of digital health technology in clinical trials: the 6R framework
4个月前
已完结
Impact of a five-dimensional framework on R&D productivity at AstraZeneca
4个月前
已完结
Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven Malignancies
4个月前
已完结
Top product forecasts for 2026
5个月前
已完结
Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe
6个月前
已完结
皖公网安备34019202002308
